OpenAI acquires Orchestra Bio

OpenAI News · 2026-10-20

OpenAI is acquiring Orchestra Bio to bring AI-powered operations to life sciences R&D, helping biopharma teams accelerate drug development and advance new treatments.

Read the original at OpenAI News

More AI news